Boosting uptake of biosimilars will require practitioner change and a policy rethink, GBMA chair says  Australia is “underdone on penetration in the market” when it comes to uptake of biosimilar medications, …

Empowering pharmacists to work to their full scope to fix Australia’s healthcare crisis, Guild president says  Pharmacists working to their full scope of practice “it not a revolution… it is …

Government urged to fund “an innovative pilot” to support rural pharmacies to deliver on expanded scope  Financial constraints are preventing remote pharmacies from participating in the provision of new services, …

Advocacy group makes pre-budget pitch for funding to improve health literacy and a biannual survey to inform health policy, but not cheaper medicines  The Australian Patients Association (APA) is calling …

Government urged to make strategic investment in primary care programs to support patients living with chronic pain  Patient Investment in primary care pain programs could help improve access to treatment …

Dedicated funding for DAAs in residential aged care facilities, and “improvements” to the Opioid Dependence Treatment Community Pharmacy Program fee structure form part of Guild’s pre-budget submission  Fresh funding is …

Students are being invited to submit expressions of interest in joining the Australian Pharmacy Council’s accreditation committee  The Australian Pharmacy Council (APC) is taking expressions of interest from students in …

Manufacturers of GLP-1 RAs such as semaglutide are being urged to invest in listing the medications on the PBS to treat obesity  The Royal Australian College of General Practitioners is …

Both sides of politics urged to commit to reducing the maximum PBS co-payment to $19 ahead of the federal election  Calls for the Pharmaceutical Benefits Scheme (PBS) general co-payment to …

Department rolls out new process for sponsors conducting market actions for therapeutic goods  The Therapeutic Goods Administration (TGA) has implemented its new Procedure for Recalls, Product Alerts and Product Corrections …

More prominent warnings added to Product Information (PI) and Consumer Medicine Information (CMI) for all oral and injectable fluoroquinolones  Updated warnings regarding rare side effects are being added to PI …

Stock market rebalancing sees wholesaler named among Australia’s top 50 biggest listed companies  Sigma Healthcare will officially join the Australian Securities Exchange (ASX) 50 on Monday 24 March 2025 following …